Citrate anticoagulation and the dynamics of thrombin generation

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 10, 2007, Pages 2055-2061

  Mann, Kenneth G ^a   Whelihan, M F ^a   Butenas, S ^a   Orfeo, T ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

Anticoagulation; Platelet aggregation; Thrombin; Thromboelastography; Thrombograms

Indexed keywords

CALCIUM ION; CITRATE SODIUM; PHOSPHOLIPID; THROMBIN; THROMBOPLASTIN;

ANTICOAGULATION; ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING; BLOOD CLOTTING TEST; CALCIUM BLOOD LEVEL; CALIBRATION; CONTROLLED STUDY; HUMAN; PRIORITY JOURNAL; PROTEOMICS; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE POOR PLASMA; THROMBOCYTE RICH PLASMA; THROMBOELASTOGRAPHY;

ANTICOAGULANTS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; CALCIUM; CALCIUM CITRATE; CALIBRATION; CITRATES; HUMANS; IONS; PLATELET ACTIVATION; PLATELET AGGREGATION; THROMBELASTOGRAPHY; THROMBIN; THROMBIN TIME;

EID: 34548840835     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02710.x     Document Type: Article

References (42)

1. Mann KG, Whelihan MF, Cooley RB, Orfeo T. Citrate blood: A century of artifact. Blood 2006; 108: 459a.
2. Owen CA Jr. A History of Blood Coagulation. Rochester, MN: Mayo Foundation for Medical Education and Research, 2001.
3. Sabbatani L. Calcium et citrate trisodique dans la coagulation du sang, de la lymphe et du lait. Arch Ital Biol 1901; 36: 397-415.
4. Sabbatani L. Fonction biologique du calcium. 1. Action antagoniste entre le citrate trisodique et le calcium. Arch Ital Biol 1901; 36: 416-8.
5. Pekelharing CA. Über die Bedutung der Kalksalze für die Gerinnung des Blutes. Int Beitr Wiss Med Virchow 1891; 1: 435-56.
6. Pekelharing CA. Über die Gerinnung des Blutes. Deutsche Med Wochenschr 1892; 18: 1133-6.
7. Quick AJ. One-stage prothrombin-time test. Lancet 1953; 1: 1307-8.
8. Langdell RD, Wagner RH, Brinkhous KM. Effect of antihemophilic factor on one-stage clotting tests: A presumptive test of hemophilia and a single one-stage anti-hemophilic factor assay procedure. J Lab Clin Med 1953; 41: 7637-47.
9. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, Lecompte T, Béquin S. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33: 4-15.
10. Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005; 27: 81-90.
11. Sunnerhagen M, Drakenberg T, Forsen S, Stenflo J. Effect of Ca2+ on the structure of vitamin K-dependent coagulation factors. Haemostasis 1996; 26: 45-53.
12. Pryzdial EL, Mann KG. The association of coagulation factor Xa and factor Va. J Biol Chem 1991; 266: 8969-77.
13. Lollar P, Knutson GJ, Fass DN. Stabilization of thrombin-activated porcine factor VIII:C by factor IXa phospholipid. Blood 1984; 63: 1303-8.
14. Esmon CT. The subunit structure of thrombin-activated factor V. Isolation of activated factor V, separation of subunits, and reconstitution of biological activity. J Biol Chem 1979; 254: 964-73.
15. Nesheim ME, Mann KG. Thrombin-catalyzed activation of single chain bovine factor V. J Biol Chem 1979; 254: 1326-34.
16. Lollar P, Fay PJ, Fass DN. Factor VIII and factor VIIIa. Methods Enzymol 1993; 222: 128-43.
17. Wakabayashi H, Koszelak ME, Mastri M, Fay PJ. Metal ion-independent association of factor VIII subunits and the roles of calcium and copper ions for cofactor activity and inter-subunit affinity. Biochemistry 2001; 40: 10293-300.
18. Woulfe D, Yang J, Prevost N, O'Brien JO, Brass LF. Signal transduction during the initiation, exstention, and perpetuation of platelet plug formation. In: Michelson AD, ed. Platelets. San Diego, CA: Academic Press, 2002: 197-213
19. Nelsestuen GL. Role of gamma-carboxyglutamic acid. An unusual protein transition required for the calcium-dependent binding of prothrombin to phospholipid. J Biol Chem 1976; 251: 5648-56.
20. Pauls JE, Hockin MF, Long GL, Mann KG. Self-association of human protein S. Biochemistry 2000; 39: 5468-73.
21. Schiodt J, Harrit N, Christensen U, Petersen LC. Two different Ca2+ ion binding sites in factor VIIa and in des (1-38) factor VIIa. FEBS Lett 1992; 306: 265-8.
22. Phillips DR, Teng W, Arfsten A, NannizziAlaimo L, White MM, Longhurst C, Shattil SJ, Randolph A, Jakubowski JA, Jennings LK, Scarborough RM. Effect of Ca2+ on GP IIb-IIIa interactions with integrilin -Enhanced GP IIb-IIIa binding and inhibition of platelet aggregation by reductions in the concentration of ionized calcium in plasma anticoagulated with citrate. Circulation 1997; 96: 1488-94.
23. Rand MD, Lock JB, van't Veer C, Gaffney DP, Mann KG. Blood clotting in minimally altered whole blood. Blood 1996; 88: 3432-45.
24. Bajaj SP, Rapaport SI, Prodanos C. A simplified procedure for purification of human prothrombin, factor IX and factor X. Prep Biochem 1981; 11: 397-412.
25. van 't Veer C, Mann KG. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin- III, and heparin cofactor-II. J Biol Chem 1997; 272: 4367-77.
26. Katzmann JA, Nesheim ME, Hibbard LS, Mann KG. Isolation of functional human coagulation factor V by using a hybridoma antibody. Proc Natl Acad Sci U S A 1981; 78: 162-6.
27. Griffith MJ, Noyes CM, Church FC. Reactive site peptide structural similarity between heparin cofactor II and antithrombin III. J Biol Chem 1985; 260: 2218-25.
28. Hojima Y, Pierce JV, Pisano JJ. Hageman factor fragment inhibitor in corn seeds: Purification and characterization. Thromb Res 1980; 20: 149-62.
29. Cawthern KM, van't Veer C, Lock JB, DiLorenzo ME, Branda RF, Mann KG. Blood coagulation in hemophilia A and hemophilia C. Blood 1998; 91: 4581-92.
30. Higgins DL, Mann KG. The interaction of bovine factor V and factor V-derived peptides with phospholipid vesicles. J Biol Chem 1983; 258: 6503-8.
31. Lawson JH, Kalafatis M, Stram S, Mann KG. A model for the tissue factor pathway to thrombin. I. An empirical study. J Biol Chem 1994; 269: 23357-66.
32. Peterson P, Gottfried EL. The effects of inaccurate blood-sample volume on prothrombin time (Pt) and activated partial thromboplastin time (Aptt). Thromb Haemost 1982; 47: 101-3.
33. Reneke J, Etzell J, Leslie S, Ng VL, Gottfried EL. Prolonged prothrombin time and activated partial thromboplastin time due to underfilled specimen tubes with 109mmol/L (3.2%) citrate anticoagulant. Am J Clin Pathol 1998; 109: 754-7.
34. Adcock DM, Kressin DC, Marlar RA. Minimum specimen volume requirements for routine coagulation testing -Dependence on citrate concentration. Am J Clin Pathol 1998; 109: 595-9.
35. Arkin CF, Adcock DM, Ernst DJ, Marlar RA, Parish GT, Szamosi DI, Warunek DJ. Collection, transport, and processing of blood specimenns for testing plasma-based coagulation assays. Approved Guideline, 4th Edn. NCCLS 23 [35] 2003
36. Luddington R., Baglin T. Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition. J Thromb Haemost 2004; 2: 1954-9.
37. Automated APTT. Product insert, 2007. Biomerieux
38. Simplastin Excel. Product insert, 2007. Biomerieux.
39. Haemoscope Corporation. Niles IL. TEG 5000 User's Manual. 1999.
40. Rivard GE., Brummel-Ziedins KE, Mann KG, Fan L, Hofer A, Cohen E. Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastography. J Thromb Haemost 2005; 3: 2039-43.
41. Dargaud Y, Luddington R, Baglin TP. Elimination of contact factor activation improves measurement of platelet-dependent thrombin generation by calibrated automated thrombography at low-concentration tissue factor. J Thromb Haemost 2006; 4: 1160-1.
42. Gailani D, Broze GJ Jr. Factor XI activation in a revised model of blood coagulation. Science 1991; 253: 909-12.